Loading clinical trials...

A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00744991

A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

The purpose of the study is to determine the efficacy and safety of enzastaurin in participants with Cutaneous T-Cell Lymphoma (CTCL) who failed prior therapies.

Lead sponsor: Eli Lilly and Company•16 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Amping up With PemJAK

NCT07283822 · Non-Hodgkin Lymphoma, Hodgkin Disease Lymphoma, and more

RECRUITING

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT06588868 · Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, and more

RECRUITING

A Registry for People With T-cell Lymphoma

NCT05978141 · T-cell Lymphoma, NK-Cell Lymphoma, and more

RECRUITINGNA

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367 · Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, and more

RECRUITINGPhase 2

Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma

NCT04128072 · Stage IB-IIB Cutaneous T-Cell Lymphoma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 19, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment25

Start dateSep 2008

Last updatedOct 19, 2020

Condition

Cutaneous T-Cell Lymphoma

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Birmingham, Alabama

Los Angeles, California

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 19, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions